Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Pfizer Ltd.

Home Clinical Trial Sponsors and OrganizationsPfizer Ltd.

Pfizer Ltd.

ACTIVE

United Kingdomwww.pfizer.co.ukSubsidiary

Part of pfizer luxco holdings sarl

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

92

89 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

32

34.8%

Unknown

1

1.1%

Trial Status Distribution

Active, not recruiting

89

96.7%

Completed

1

1.1%

Recruiting

2

2.2%

Clinical Trials

Trials sponsored by this organization (92)

An Immuno-Dermatological disease registry in Indian Patients

Jul 20233,000 participants

An Open Label Access Study For Subjects Who Completed A1481156

Active, not recruiting

Jun 20154 participants

A PHASE IIb RANDOMISED DOUBLE BLIND, PLACEBO CONTROLLED PARALLEL GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-00610355 OVER 4 WEEKS IN MODERATE ASTHMATIC SUBJECTS

Active, not recruiting

Jan 2009356 participants

OPEN-LABEL, NON-COMPARATIVE, STUDY OF INTRAVENOUSANIDULAFUNGIN, FOLLOWED OPTIONALLY BY ORAL VORICONAZOLE ORFLUCONAZOLE THERAPY, FOR TREATMENT OF DOCUMENTEDCANDIDEMIA/INVASIVE CANDIDIASIS IN INTENSIVE CARE UNIT PATIENTPOPULATIONS

Active, not recruiting

Jan 2009186 participants

A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, EFFICACY AND SAFETY STUDY OF MONOTHERAPY SITAXSENTAN SODIUM VERSUS COMBINATION THERAPY WITH SITAXSENTAN SODIUM AND SILDENAFIL CITRATE IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSION WHO HAVE COMPLETED STUDY B1321001

Active, not recruiting

Dec 2008150 participants

A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,SAFETY AND EFFICACY STUDY OF SITAXSENTAN SODIUM IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSIO

Active, not recruiting

Dec 2008150 participants

A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTAN SODIUM AND COMBINATION THERAPY WITH SITAXSENTAN SODIUM AND SILDENAFIL CITRATE IN SUBJECTS WITH PULMONARY ARTERIAL HYPERTENSIO

Active, not recruiting

Dec 2008150 participants

OPEN-LABEL, NON-COMPARATIVE, STUDY OF INTRAVENOUSANIDULAFUNGIN, FOLLOWED OPTIONALLY BY ORAL VORICONAZOLE ORFLUCONAZOLE THERAPY, FOR TREATMENT OF DOCUMENTEDCANDIDEMIA/INVASIVE CANDIDIASIS IN INTENSIVE CARE UNIT PATIENTPOPULATIONS

Active, not recruiting

Oct 2008286 participants

Page 1 of 12

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials92
Approvals
News

Back to Organizations